Mr. Ibrahem/Pirfenidone
Clinical data
Trade namesEsbriet, Pirespa, Etuary, others
AHFS/Drugs.comMonograph
MedlinePlusa615008
License data
Routes of
administration
By mouth
Legal status
Legal status
  • UK: POM (Prescription only)
  • US: ℞-only
  • EU: Rx-only
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding50–58%[1]
MetabolismHepatic (70–80% CYP1A2-mediated; minor contributions from CYP2C9, CYP2C19, CYP2D6 and CYP2E1)[1]
Elimination half-life2.4 hours[1]
ExcretionUrine (80%)[1]
Identifiers
  • 5-Methyl-1-phenylpyridin-2-one
Chemical and physical data
FormulaC12H11NO
Molar mass185.226 g·mol−1
3D model (JSmol)
Solubility in water10mg/mL at 60 °C
  • CC1=CN(C(=O)C=C1)C2=CC=CC=C2
  • InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3
  • Key:ISWRGOKTTBVCFA-UHFFFAOYSA-N
 ☒NcheckY (what is this?)  (verify)

Pirfenidone, sold under the brand name Pirespa among others, is a medication used to treat idiopathic pulmonary fibrosis.[2] It is used for mild to moderate disease.[4] It is taken by mouth.[2]

Common side effects include nausea, rash, tiredness, heartburn, headache, and sunburns.[2] Other side effects may include liver problems.[3] Safety in pregnancy is not clear.[5] How it works is not entire clear, however it reduces the production of fibroblasts.[2]

Pirfenidone was approved for medical use in Europe in 2011 and the United States in 2014.[2][3] In the United Kingdom 4 weeks of medication costs the NHS about £2,000 as of 2021.[4] In the United States this amount is about 9,900 USD.[6]

References

edit
  1. ^ a b c d "Esbriet 267 mg hard capsules". electronic Medicines Compendium. Intermune UK & I Ltd. 3 January 2014. Archived from the original on 12 October 2013. Retrieved 6 March 2014.
  2. ^ a b c d e f g "Esbriet". Archived from the original on 24 November 2020. Retrieved 28 October 2021.
  3. ^ a b c "Pirfenidone Monograph for Professionals". Drugs.com. Archived from the original on 21 June 2020. Retrieved 28 October 2021.
  4. ^ a b BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 314. ISBN 978-0857114105.
  5. ^ "Pirfenidone (Esbriet) Use During Pregnancy". Drugs.com. Archived from the original on 27 January 2021. Retrieved 28 October 2021.
  6. ^ "Esbriet Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 28 January 2021. Retrieved 28 October 2021.